首页> 美国卫生研究院文献>BMJ Open >Patterns of peritoneal dissemination and response to systemic chemotherapy in common and rare peritoneal tumours treated by cytoreductive surgery: study protocol of a prospective multicentre observational study
【2h】

Patterns of peritoneal dissemination and response to systemic chemotherapy in common and rare peritoneal tumours treated by cytoreductive surgery: study protocol of a prospective multicentre observational study

机译:腹膜传播模式和细胞导致手术治疗常见和罕见腹膜肿瘤的全身化疗的响应:研究方案的潜在多期观测研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Despite optimal patient selection and surgical effort, recurrence is seen in over 70% of patients undergoing cytoreductive surgery (CRS) for peritoneal metastases (PM). Apart from the Peritoneal Cancer Index (PCI), completeness of cytoreduction and tumour grade, there are other factors like disease distribution in the peritoneal cavity, pathological response to systemic chemotherapy (SC), lymph node metastases and morphology of PM which may have prognostic value. One reason for the underutilisation of these factors is that they are known only after surgery. Identifying clinical predictors, specifically radiological predictors, could lead to better utilisation of these factors in clinical decision making and the extent of peritoneal resection performed for different tumours. This study aims to study these factors, their impact on survival and identify clinical and radiological predictors.
机译:尽管有最佳的患者选择和外科努力,但在腹膜转移(PM)的患者中有超过70%的患者中出现复发。除了腹膜癌指数(PCI),细胞渗透和肿瘤等级的完整性,还有其他因素,如疾病分布等因素,腹膜腔内,对全身化疗(SC),淋巴结转移和PM的形态有可能具有预后价值的病理反应。未充分利用这些因素的一个原因是它们仅在手术后才知道。鉴定临床预测因子,特别是放射预测因子,可以更好地利用这些因素在临床决策中以及对不同肿瘤进行的腹膜切除程度。本研究旨在研究这些因素,它们对存活率的影响和鉴定临床和放射性预测因子。

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号